BUY Balrampur Chini Mills Limited — Manas Jaiswal
byManas JaiswalHorizon: 1–3 months2 Sept 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
MACD above its signal line — bullish momentum
Technicals · macd·25 Oct · today
Balrampur Chini can see 30% upside in two years, says Elara Securities’ Prashant Biyani
NewsCnbc-Tv18·13 Oct · 2w ago
1 advisor has an active long-term BUY call on this stock
Advisor consensus · adjacent horizon·31 Aug · 2mo ago
1 other SEBI-registered advisor has an active short-term BUY call on this stock
Advisor consensus · same horizon·21 Aug · 2mo ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Balrampur Chini Mills
- BUY — Somil Mehta, Sharekhan16 Oct 2026 · ~3 months · target ₹800 · SL hit
- BUY — IDBI Capital13 Oct 2026 · ~3 months · target ₹778 · SL hit
- BUY — Amol Athawale, Kotak Securities13 Oct 2026 · ~3 months · target ₹740 · SL hit
- BUY — Rajesh Satpute12 Oct 2026 · ~2 weeks · target ₹740 · SL hit
- BUY — IDBI Capital12 Oct 2026 · ~2 weeks · target ₹723 · Target hit
More from Manas Jaiswal
- BUY Ajanta Pharma23 Oct 2026 · Same day · target ₹3,425 · SL hit
- BUY Torrent Pharmaceuticals23 Oct 2026 · Same day · target ₹4,725 · SL hit
- BUY SAGILITY23 Oct 2026 · ~2 weeks · target ₹50 · SL hit
- BUY Zydus Lifesciences22 Oct 2026 · ~3 months · target ₹1,160 · SL hit
- BUY IPCA Laboratories22 Oct 2026 · ~2 weeks · target ₹2,000 · Active

